Andrew A. Hindman - Net Worth and Insider Trading
Andrew A. Hindman Net Worth
The estimated net worth of Andrew A. Hindman is at least $4 Million dollars as of 2024-05-11. Andrew A. Hindman is the SVP, CHIEF FINANCIAL OFFICER of Theravance Biopharma Inc and owns about 384,714 shares of Theravance Biopharma Inc (TBPH) stock worth over $4 Million. Andrew A. Hindman is also the Chief Business Officer of Acorda Therapeutics Inc and owns about 38 shares of Acorda Therapeutics Inc (ACORQ) stock worth over $17. Details can be seen in Andrew A. Hindman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Andrew A. Hindman has not made any transactions after 2022-11-18 and currently still holds the listed stock(s).
Transaction Summary of Andrew A. Hindman
Andrew A. Hindman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew A. Hindman owns 2 companies in total, including Theravance Biopharma Inc (TBPH) , and Acorda Therapeutics Inc (ACORQ) .
Click here to see the complete history of Andrew A. Hindman’s form 4 insider trades.
Insider Ownership Summary of Andrew A. Hindman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2022-11-18 | SVP & Chief Financial Officer |
| ACORQ | Acorda Therapeutics Inc | 2018-05-25 | Chief Business Dev. Officer |
Andrew A. Hindman Latest Holdings Summary
Andrew A. Hindman currently owns a total of 2 stocks. Among these stocks, Andrew A. Hindman owns 384,714 shares of Theravance Biopharma Inc (TBPH) as of November 18, 2022, with a value of $4 Million and a weighting of 100%. Andrew A. Hindman also owns 38 shares of Acorda Therapeutics Inc (ACORQ) as of May 25, 2018, with a value of $17 and a weighting of 0%.
Latest Holdings of Andrew A. Hindman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TBPH | Theravance Biopharma Inc | 2022-11-18 | 384,714 | 9.38 | 3,608,617 |
| ACORQ | Acorda Therapeutics Inc | 2018-05-25 | 38 | 0.44 | 17 |
Holding Weightings of Andrew A. Hindman
Andrew A. Hindman Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew A. Hindman has made a total of 1 transactions in Theravance Biopharma Inc (TBPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Theravance Biopharma Inc is the sale of 65,000 shares on November 18, 2022, which brought Andrew A. Hindman around $716,300.
According to the SEC Form 4 filings, Andrew A. Hindman has made a total of 0 transactions in Acorda Therapeutics Inc (ACORQ) over the past 5 years. The most-recent trade in Acorda Therapeutics Inc is the sale of 355 shares on May 25, 2018, which brought Andrew A. Hindman around $1 Million.
Insider Trading History of Andrew A. Hindman
- 1
Andrew A. Hindman Trading Performance
Andrew A. Hindman Ownership Network
Andrew A. Hindman Owned Company Details
What does Theravance Biopharma Inc do?
Who are the key executives at Theravance Biopharma Inc?
Andrew A. Hindman is the SVP & Chief Financial Officer of Theravance Biopharma Inc. Other key executives at Theravance Biopharma Inc include 10 percent owner Eli Samaha , SVP & Comm & Medical Affairs Rhonda Farnum , and SVP & Development Richard A Graham .
Theravance Biopharma Inc (TBPH) Insider Trades Summary
Over the past 18 months, Andrew A. Hindman made 1 insider transaction in Theravance Biopharma Inc (TBPH) with a net sale of 65,000. Other recent insider transactions involving Theravance Biopharma Inc (TBPH) include a net sale of 25,787 shares made by Richard A Graham , a net sale of 10,229 shares made by Rhonda Farnum , and a net purchase of 1,499,124 shares made by Eli Samaha .
In summary, during the past 3 months, insiders sold 1,254 shares of Theravance Biopharma Inc (TBPH) in total and bought 1,499,124 shares, with a net purchase of 1,497,870 shares. During the past 18 months, 151,016 shares of Theravance Biopharma Inc (TBPH) were sold and 1,499,124 shares were bought by its insiders, resulting in a net purchase of 1,348,108 shares.
Theravance Biopharma Inc (TBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Theravance Biopharma Inc Insider Transactions
Andrew A. Hindman Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew A. Hindman. You might contact Andrew A. Hindman via mailing address: C/o Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley Ny 10502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
